Show simple item record

dc.contributor.authorDolzhenko, Anton
dc.contributor.authorFoo, M.
dc.contributor.authorTan, B.
dc.contributor.authorDolzhenko, A.
dc.contributor.authorChiu, G.
dc.contributor.authorChui, W.
dc.date.accessioned2017-01-30T11:37:09Z
dc.date.available2017-01-30T11:37:09Z
dc.date.created2011-08-17T20:01:14Z
dc.date.issued2009
dc.identifier.citationDolzhenko, Anton V. and Foo, Mi Chelle. and Tan, Ben Jee. and Dolzhenko, Anna V. and Chiu, Gigi Ngar Chee. and Chui, Wai Keung. 2009. Synthesis and Heterocyclizations of 3,4-Dihydroquinazolin-2-yl Guanidine in the Search of New Anticancer Agents. Heterocycles. 78 (7): pp. 1761-1775.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/13442
dc.description.abstract

The cyclocondensations of 3,4-dihydroquinazolin-2-yl guanidine with a variety of electrophilic reagents viz. aldehydes, ketones, triethyl orthoformate, diethyl ethoxymethylenemalonate, carbon disulfide and trichloroacetonitrile were found to afford 1,3,5-triazino[2,1-b]quinazolines. However, some unexpected reactions were also observed. The structural properties such as tautomerism and hinderance to conformational rotation were also investigated. The results of biological testing suggested that the 1,3,5-triazino[2,1-b]quinazoline nucleus could be a new promising scaffold for the development of potential anticancer agents.

dc.publisherThe Japan Institute of Heterocyclic Chemistry
dc.titleSynthesis and Heterocyclizations of 3,4-Dihydroquinazolin-2-yl Guanidine in the Search of New Anticancer Agents
dc.typeJournal Article
dcterms.source.volume78
dcterms.source.number7
dcterms.source.startPage1761
dcterms.source.endPage1775
dcterms.source.issn1881-0942
dcterms.source.titleHeterocycles
curtin.departmentSchool of Pharmacy
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record